MARKET

NERV

NERV

Minerva Neurosci
NASDAQ
5.97
+0.05
+0.84%
Closed 18:11 05/31 EDT
OPEN
5.78
PREV CLOSE
5.92
HIGH
6.07
LOW
5.62
VOLUME
32.34K
TURNOVER
--
52 WEEK HIGH
15.27
52 WEEK LOW
1.260
MARKET CAP
33.24M
P/E (TTM)
-1.0875
1D
5D
1M
3M
1Y
5Y
Minerva Neurosciences: Up About 250 Percent Since April With An FDA Catalyst Ahead
Seeking Alpha · 05/19 21:34
What Makes Minerva Neurosciences (NERV) a New Buy Stock
NASDAQ · 05/18 16:00
Analysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX), Cara Therapeutics (CARA) and Minerva Neurosciences (NERV)
TipRanks · 05/16 10:20
HC Wainwright & Co. Reiterates Neutral on Minerva Neurosciences, Maintains $8 Price Target
Benzinga · 05/16 10:12
BRIEF-Minerva Neurosciences Reports 2023 First Quarter Financial Results And Business Updates
Reuters · 05/15 11:53
Minerva Neurosci: Quarterly report
Press release · 05/15 07:03
Notable earnings before Monday's open
Seeking Alpha · 05/12 14:44
Minerva soars ~10% as schizophrenia drug gets FDA review
Seeking Alpha · 05/10 13:06
More
About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company's lead product candidates are roluperidone (MIN-101) and MIN-301. Roluperidone (MIN-101) is a compound that blocks serotonin, sigma, and α adrenergic receptors that are involved in the regulation of mood, cognition, sleep, and anxiety. The Company is developing roluperidone to treat patients with schizophrenia. Roluperidone is designed to block a specific subtype of serotonin receptor called 5-HT2A. The Company’s MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1), protein, for the treatment of Parkinson’s disease and for other neurodegenerative disorders. The Company is also developing seltorexant for the treatment of insomnia disorder and adjunctive treatment of the major depressive disorder (MDD).

Webull offers kinds of Minerva Neurosciences Inc stock information, including NASDAQ:NERV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NERV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NERV stock methods without spending real money on the virtual paper trading platform.